MK-8655

MK-8655 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8655, covering 2018-11-13 to 2018-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-8655 in Participants With Type 2 Diabetes (MK-8655-002) [Phase 1]

See pricing